Rituximab (anti-CD20)
Product Sizes
50 mg
£ POA
HY-P9913A-50MG
25 mg
£ POA
HY-P9913A-25MG
10 mg
£ POA
HY-P9913A-10MG
1 mg
£ POA
HY-P9913A-1MG
5 mg
£ POA
HY-P9913A-5MG
About this Product
- SKU:
- HY-P9913A
- CAS Number:
- 174722-31-7
- Extra Details:
- Rituximab (anti-CD20) is an anti-CD20 chimeric monoclonal antibody used to treat certain autoimmune diseases and types of cancer[1].
- Molecular Weight:
- (143.47 kDa)
- Purity:
- 99.10
- References:
- [1]Kamburova EG, et al. In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells. Am J Transplant. 2012 Feb;12(2):341-50.|[2]Manches O, et al. In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas. Blood. 2003 Feb 1;101(3):949-54.|[3]Byrd JC, et al. The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction. Blood. 2002 Feb 1;99(3):1038-43.
- Research Area:
- Cancer; Inflammation/Immunology
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- Store at 4[o]C for 2 years; do not freeze
- Type:
- Antibodies
- Pathway:
- Immunology/Inflammation
